Tosyl phenylalanyl chloromethyl ketone
Tosyl phenylalanyl chloromethyl ketone (TPCK) is a protease inhibitor. Its structural formula is 1-chloro-3-tosylamido-4-phenyl-2-butanone.
Names | |
---|---|
Preferred IUPAC name
N-[(2S)-4-Chloro-3-oxo-1-phenylbutan-2-yl]-4-methylbenzene-1-sulfonamide | |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
ECHA InfoCard | 100.006.323 |
MeSH | Tosylphenylalanyl+Chloromethyl+Ketone |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C17H18ClNO3S | |
Molar mass | 351.848 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Uses
editTPCK is an irreversible inhibitor of chymotrypsin. Also inhibits some cysteine proteases such as caspase, papain, bromelain or ficin.[1] It does not inhibit trypsin or zymogens.
TPCK is observed covalently bound in the active site of Caspase 3 in the crystal structure of the complex solved in 2010.[2] The chloromethyl group reacts with the active site cysteine to form a covalent bond with the loss of the chlorine.
TPCK is chosen for the chemical labelling of active histidine in enzyme analysis. The phenylalanine moiety is bound to the enzyme because of specificity for aromatic amino acid residues at the active site (as in chymotrypsin, in which it binds to the histidine-57 residue in the active site).[3]
Virology
editTPCK-treated trypsin is used to improve infection yield in laboratory tissue culture of some wild virus isolates that are not well-adapted to growth in vitro, such as some low-pathogenic avian influenza strains or fresh clinical isolates of SARS-CoV-2. The trypsin performs the maturation cleavage of the viral envelope proteins efficiently.
References
edit- ^ Focus Biomolecules Catalog # 10-2290 TPCK. [1], Retrieved on May 23. 2013.
- ^ Ganesan et al. Acta Crystallogr F v67 p 842. PDB Entry 2xyg
- ^ Farrell, Shawn O.; Campbell, Mary K. (2006). Biochemistry. Australia: Thomson Brooks/Cole. p. 160. ISBN 0-534-39499-X.